Mariner Wealth Advisors (NYC)’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Mariner Wealth Advisors (NYC)’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$5K	Buy	+17	New	+$3.68K	﹤0.01%	523

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Mariner Wealth Advisors (NYC)'s ICPT Position: Q1 2015 in Review

Mariner Wealth Advisors (NYC) opened a new position in Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2015: 17 shares worth $5K. The stake represents ﹤0.01% of the portfolio and ranks #523 among its holdings.

200 funds tracked by Wall St. Rank hold ICPT as of Q1 2015.

Mariner Wealth Advisors (NYC) held 17 shares of Intercept Pharmaceuticals, Inc. worth $5K as of Q1 2015.
Intercept Pharmaceuticals, Inc. was a new Mariner Wealth Advisors (NYC) position in Q1 2015.
Intercept Pharmaceuticals, Inc. made up ﹤0.01% of Mariner Wealth Advisors (NYC)'s portfolio in Q1 2015, its #523 holding.
200 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2015.

Based on Mariner Wealth Advisors (NYC)'s 13F filing for Q1 2015, filed 14 May 2015.